Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier.

MLA

Huang, Qin, et al. “Targeting AAV Vectors to the Central Nervous System by Engineering Capsid-Receptor Interactions That Enable Crossing of the Blood-Brain Barrier.” PLoS Biology, vol. 21, no. 7, July 2023, p. e3002112. EBSCOhost, https://doi.org/10.1371/journal.pbio.3002112.

APA

Huang, Q., Chen, A. T., Chan, K. Y., Sorensen, H., Barry, A. J., Azari, B., Zheng, Q., Beddow, T., Zhao, B., Tobey, I. G., Moncada-Reid, C., Eid, F.-E., Walkey, C. J., Ljungberg, M. C., Lagor, W. R., Heaney, J. D., Chan, Y. A., & Deverman, B. E. (2023). Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier. PLoS Biology, 21(7), e3002112. https://doi.org/10.1371/journal.pbio.3002112

Chicago

Huang, Qin, Albert T Chen, Ken Y Chan, Hikari Sorensen, Andrew J Barry, Bahar Azari, Qingxia Zheng, et al. 2023. “Targeting AAV Vectors to the Central Nervous System by Engineering Capsid-Receptor Interactions That Enable Crossing of the Blood-Brain Barrier.” PLoS Biology 21 (7): e3002112. doi:10.1371/journal.pbio.3002112.